Conventional Clinical Trials
What is a Clinical Trial?
Clinical trials test new drugs, equipment, and treatments the US Food and Drug Administration (FDA) has not yet approved, along with new surgical techniques. Clinical trials also may test a new drug with standard treatment that is already FDA approved. Patients choose to participate in clinical trials for a variety of reasons:
- To try a new and promising treatment method
- To contribute to the development of future treatments
- To help find a cure for a specific disease or illness
“We have a new drug and need to test what dosage is safe for humans.”
- 20-80 participants
- 1-2 years
- Studies Safety
“We know the drug is safe, now we need to determine how well the drug works.”
- 100-300 participants
- 2-3 years
- Studies Efficacy
“The drug shows promise, now we need to learn if the new treatment is better than the current standard of care.”
- 1,000-3,000 participants
- 3-6 years
- FDA Approval
Conventional Clinical Trials Require Time You Simply Don’t Have
For most brain tumor patients, enrolling in conventional clinical trials involves a leap of faith. After being prescribed a new treatment, you may struggle through significant side effects and the agonizing wait for results several months later.
Under ideal circumstances, the experimental therapies stops disease progression and, in these cases, the time and effort invested by you and your family were worthwhile. Unfortunately, a more common result is that the new therapy is ineffective, costing you precious time and energy as you, once again, face another set of imperfect treatment options. Phase 0 clinical trials are a way to avoid all of this.